B. Riley Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

B. Riley Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,457	Closed	-$229K	–	163
2015 Q3	$229K	Sell	3,457 -3,408	-50%	-$265K	0.32%	125
2015 Q2	$537K	Sell	6,865 -150	-2%	-$11.7K	0.43%	45
2015 Q1	$535K	Sell	7,015 -1,426	-17%	-$105K	0.4%	57
2014 Q4	$561K	Buy	8,441 +100	+1%	+$6.66K	0.46%	45
2014 Q3	$530K	Sell	8,341 -270	-3%	-$16.7K	0.39%	57
2014 Q2	$525K	Sell	8,611 -337	-4%	-$19.5K	0.34%	67
2014 Q1	$507K	Buy	+8,948	New	+$508K	0.37%	58

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

B. Riley Wealth Management's PJP Position: Q4 2015 in Review

B. Riley Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2015, closing a stake of 3,457 shares — an estimated $229K sold.

B. Riley Wealth Management first reported a position in PJP in Q1 2014 and held it in 7 quarters. The position peaked at $561K in Q4 2014. 112 funds tracked by Wall St. Rank hold PJP as of Q4 2015.

B. Riley Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
B. Riley Wealth Management sold 3,457 Invesco Pharmaceuticals ETF shares in Q4 2015, an estimated $229K.
B. Riley Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and held it in 7 quarters.
B. Riley Wealth Management's Invesco Pharmaceuticals ETF position peaked at $561K in Q4 2014.
112 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2015.

Based on B. Riley Wealth Management's 13F filing for Q4 2015, filed 8 Jan 2016.